The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / CMS Announces Timeline for Drug Negotiations

CMS Announces Timeline for Drug Negotiations

January 20, 2023 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A significant provision in the Inflation Reduction Act allows the Centers for Medicare & Medicaid Services (CMS) to negotiate drug pricing. Earlier this month, the CMS released the initial timeline for the development of this negotiation process.

You Might Also Like
  • CMS Proposes New Part B Drug Payment Model
  • Joint Letter to CMS Advocates Against Adding Stelara to Self-Administered Drug List
  • CMS Announces 90% Cut to Obamacare’s Advertising Budget
Also By This Author
  • ACR Seeks Awards and Masters Nominations

This winter and spring, the CMS will outline key elements needed for negotiation, including the data collection sources and methodologies used to apply maximum fair prices. The CMS will seek public comments on these elements.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

By Sept. 1, 2023, the CMS will release the list of the 10 drugs that will be up for negotiation for the initial price applicability year. The negotiation process will begin in fall 2023 and continue until summer 2024, after which the CMS will publish the maximum fair prices for the 10 selected drugs. The new prices will become effective on Jan. 1, 2026. The negotiation process will occur annually, with additional medications selected for each cycle.

The ACR looks forward to actively participating in all public comment opportunities during this process.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Legislation & Advocacy Tagged With: ACR advocacy, Centers for Medicare & Medicaid Services (CMS), drug price negotiation

You Might Also Like:
  • CMS Proposes New Part B Drug Payment Model
  • Joint Letter to CMS Advocates Against Adding Stelara to Self-Administered Drug List
  • CMS Announces 90% Cut to Obamacare’s Advertising Budget
  • CMS Acts on the ACR’s Requests & Announces ICD-10 Grace Period

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)